| Followers | 52 |
| Posts | 14237 |
| Boards Moderated | 0 |
| Alias Born | 06/15/2014 |
Saturday, December 21, 2024 5:36:45 PM
I will say that there seems to be one point that he may have and that I find confusing myself. If anyone can better explain this one top line bullet point in the press release I would appreciate it:
Operator
05/09/2024 at 06:17 PM
This is a common misconception that this strip is common area, but it is actually a part of your lot and needs to be maintained the same as your lawn. No worries though, we are only recently sending out letters/citations about landscape maintenance so you do not need to worry about being fined in the meantime. For reference, it takes close to two months for us to issue fines following the initial citation, so you have plenty of time to make arrangements to accommodate this.
"14.5% relative improvement in DFS observed at 54 months for the CAN-2409 treatment arm compared to the placebo control arm"
I am not sure exactly what they are saying. I know AF also questions why specifically the 54 months. TIA
Recent CADL News
- Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors • GlobeNewswire Inc. • 03/17/2026 12:05:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/12/2026 12:58:28 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 12:17:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 12:10:26 PM
- Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/12/2026 12:05:00 PM
- Candel Therapeutics To Present New Data after Extended Follow Up from Randomized Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting • GlobeNewswire Inc. • 03/09/2026 12:05:00 PM
- Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/02/2026 09:05:00 PM
- Candel Therapeutics to Present at TD Cowen’s 46th Annual Health Care Conference in Boston • GlobeNewswire Inc. • 02/24/2026 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 01:00:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/20/2026 09:16:14 PM
- Candel Therapeutics Announces Pricing of Public Offering • GlobeNewswire Inc. • 02/20/2026 02:40:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/19/2026 09:31:42 PM
- Candel Therapeutics Announces Proposed $100 Million Public Offering • GlobeNewswire Inc. • 02/19/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/19/2026 09:03:06 PM
- Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer • GlobeNewswire Inc. • 02/19/2026 09:01:00 PM
- Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit • GlobeNewswire Inc. • 02/11/2026 01:05:00 PM
- Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/02/2026 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 10:04:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 10:02:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 10:01:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 10:00:12 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/21/2026 05:30:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 01:30:52 PM
- Candel Therapeutics to Host Virtual R&D Event on December 5, 2025 • GlobeNewswire Inc. • 11/17/2025 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 01:30:54 PM
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
